4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-22-000057
EVP, Chief Financial Officer returned 1,951 shares (to the company)
- EVP, Chief Financial Officer acquired 5,297 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sylvain Jereme M EVP, Chief Financial Officer | 2022-03-08 | Grant or award | +5,297 | $0.00 | $5 | 19,959 | D: show line 1 in the form |
| Sylvain Jereme M EVP, Chief Financial Officer | 2022-03-09 | Returned to the company | −491 | $406.06 | $199,374 | 19,468 | D: show line 2 in the form |
| Sylvain Jereme M EVP, Chief Financial Officer | 2022-03-09 | Returned to the company | −844 | $406.06 | $342,712 | 18,624 | D: show line 3 in the form |
| Sylvain Jereme M EVP, Chief Financial Officer | 2022-03-09 | Returned to the company | −424 | $406.06 | $172,168 | 18,200 | D: show line 4 in the form |
| Sylvain Jereme M EVP, Chief Financial Officer | 2022-03-09 | Returned to the company | −192 | $406.06 | $77,963 | 18,008 | D: show line 5 in the form |
Loading xslF345X03/edgardoc.xml…